المؤلفون: Xu, Midie, Yan, Jiuliang, Hu, Beiyuan, Wu, Chuntao, Gu, Haitao, Qi, Zihao, Chen, Tao, Yang, Wenting, Zheng, Yan, Dong, Hanguang, Sheng, Weiqi, Long, Jiang

المصدر: Genes; Sep2022, Vol. 13 Issue 9, p1588-1588, 13p

مصطلحات موضوعية: PANCREATIC tumors, NEUROENDOCRINE tumors, LIVER metastasis, METASTASIS, PROGNOSIS, CELL cycle regulation, GENETIC mutation

المؤلفون: Gao, Heli, Wang, Wenquan, Xu, Huaxiang, Wu, Chuntao, Jin, Wei, Zhang, Shirong, Xu, Jinzhi, Ni, Quanxing, Yu, Xianjun, Liu, Liang

المصدر: Pancreatology (Elsevier Science); Apr2019, Vol. 19 Issue 3, p472-477, 6p

المؤلفون: Li, Shuo, Xu, Huaxiang, Wu, Chuntao, Wang, Wenquan, Jin, Wei, Gao, Heli, Li, Hao, Zhang, Shirong, Xu, Jinzhi, Zhang, Wuhu, Xu, Shuaishuai, Li, Tianjiao, Ni, Quanxing, Yu, Xianjun, Liu, Liang

المصدر: Cancer Medicine; Feb2019, Vol. 8 Issue 2, p572-584, 13p

مصطلحات موضوعية: CA 19-9 test, PANCREATIC surgery, PROGNOSIS, LIVER function tests, SURVIVAL analysis (Biometry), OBSTRUCTIVE jaundice

المؤلفون: Wu, Chuntao, Camacho, Fabian T., King, Spencer B., Walford, Gary, Holmes, David R., Stamato, Nicholas J., Berger, Peter B., Sharma, Samin, Curtis, Jeptha P., Venditti, Ferdinand J., Jacobs, Alice K., Hannan, Edward L.

مصطلحات موضوعية: Aged, 80 and over, Male, Time Factors, Age Factors, New York, Comorbidity, Coronary Artery Disease, Middle Aged, Prognosis, Survival Analysis, Article, Body Mass Index, Cohort Studies, Percutaneous Coronary Intervention, Risk Factors, Humans, Female, Risk Adjustment, Aged, Follow-Up Studies, Proportional Hazards Models

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::13018c264a1218e40da3093dbd55d4abTest
https://europepmc.org/articles/PMC4121885Test/

المؤلفون: Xiang, Jinfeng^1,2,3, Liu, Liang^1,2,3, Wang, Wenquan^1,2,3, Xu, Huaxiang^1,2,3, Wu, Chuntao^1,2,3, Xu, Jin^1,2,3, Liu, Chen^1,2,3, Long, Jiang^1,2,3, Ni, Quanxing^1,2,3, Yu, Xianjun^1,2,3 yuxianjun@fudan.edu.cn

المصدر: Cancer Letters. Apr2015, Vol. 359 Issue 2, p165-168. 4p.

مصطلحات موضوعية: *PANCREATIC cancer treatment, *PANCREATIC cancer, *INDIVIDUALIZED medicine, *ADENOCARCINOMA, *METABOLOMICS, *HEALTH outcome assessment, *MEDICAL decision making, *PROGNOSIS